228 related articles for article (PubMed ID: 10425206)
1. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.
Pelton PD; Zhou L; Demarest KT; Burris TP
Biochem Biophys Res Commun; 1999 Aug; 261(2):456-8. PubMed ID: 10425206
[TBL] [Abstract][Full Text] [Related]
2. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
3. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.
Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H
Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
5. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes.
Rosenbaum SE; Greenberg AS
Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells.
Oyama Y; Akuzawa N; Nagai R; Kurabayashi M
Circ Res; 2002 Feb; 90(3):348-55. PubMed ID: 11861425
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
8. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
Marx N; Sukhova G; Murphy C; Libby P; Plutzky J
Am J Pathol; 1998 Jul; 153(1):17-23. PubMed ID: 9665460
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone, a PPARgamma ligand, inhibits osteopontin gene expression in human monocytes/macrophage THP-1 cells.
Oyama Y; Kurabayashi M; Akuzawa N; Nagai R
J Atheroscler Thromb; 2000; 7(2):77-82. PubMed ID: 11426586
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
13. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD
Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
17. Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts.
Bastie C; Holst D; Gaillard D; Jehl-Pietri C; Grimaldi PA
J Biol Chem; 1999 Jul; 274(31):21920-5. PubMed ID: 10419513
[TBL] [Abstract][Full Text] [Related]
18. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
[TBL] [Abstract][Full Text] [Related]
20. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
